Journal article

The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia

A randomized control trial conducted in Zambia in 2019 to assess the impact of switch to 5-dose vials for the Measles-Rubella vaccine in routine immunization. The study found that MCV1 increased 4.9% (MCV2 increased 3.5%) and​ wastage decreased 47% with the switch to a smaller presentation size.

Languages

  • English

Publication year

2020

Journal

Vaccine

Volume

38

Issue

37

Type

Journal article

Categories

  • Service delivery

Diseases

  • Measles
  • Rubella

Countries

  • Zambia

Tags

  • Coverage monitoring
  • Vaccine presentation and packaging
  • Wastage

WHO Regions

  • African Region

PORTFOLIO-LESSONS

This resource appears in the following Hot Topic page:

The resource is included in the following table:

TitleAuthorYearTypeLanguage
The switch from ROTARIX to ROTAVAC in Ghana: Answers to four key questionsPATH2022ReportEnglish
The Health Benefits of Rotavirus Immunization for Children in Palestine: Results of a Vaccine Impact AnalysisPATH, Rostropovich-Vishnevskaya Foundation, Palestine Ministry of Health2021ReportRussian
Economic Implications of Switching Rotavirus Vaccine Products in Palestine's Immunization ProgramPATH2020Case studyArabic, English, Russian, French
Introducing 5-dose Measles-Rubella Vaccine Vials in Zambia: Research FindingsDose Per Container Partnership (DPCP), JSI2019Case studyEnglish
The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in ZambiaKirstin Krudwig, Barbara Knittel, Ali Karim, Natasha Kanagat, Wendy Prosser, Guissimon Phiri, Frances Mwansa, Robert Steinglass2020Journal articleEnglish
A Switch for Sustainability in Ghana's Rotavirus Vaccine ProgramGeorge Armah2020Case studyEnglish
The Operational Impact of Switching from a Two-Dose to a One-Dose HPV Vaccination Schedule: Lessons Learned from Burkina Faso, Ethiopia, and Solomon Islands HAPPI2025ReportEnglish
Economic implications of switching to the hexavalent infant vaccine in an immunization program in IndiaPawan Kumar, Kapil Singh, Arindam Ray, Arup Deb Roy, Susmita Chatterjee, Homero Hernandez, Amrita Kumari2026Journal articleEnglish